These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9850638)

  • 21. Immunohistochemical differentiation of malignant mesothelioma, mesothelial hyperplasia and metastatic adenocarcinoma in serous effusions, utilizing staining for carcinoembryonic antigen, keratin and vimentin.
    Duggan MA; Masters CB; Alexander F
    Acta Cytol; 1987; 31(6):807-14. PubMed ID: 2447718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. P53 in squamous metaplasia: a marker for risk of respiratory tract carcinoma.
    Boers JE; ten Velde GP; Thunnissen FB
    Am J Respir Crit Care Med; 1996 Jan; 153(1):411-6. PubMed ID: 8542151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Significance of immunocytochemical expression of E-cadherin, N-cadherin and CD44 in serous effusions using liquid-based cytology.
    Malle D; Valeri RM; Photiou C; Kaplanis K; Andreadis C; Tsavdaridis D; Destouni C
    Acta Cytol; 2005; 49(1):11-6. PubMed ID: 15717748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p53 mutations as tumor markers in fine needle aspirates of palpable breast masses.
    Dillon DA; Hipolito E; Zheng K; Rimm DL; Costa JC
    Acta Cytol; 2002; 46(5):841-7. PubMed ID: 12365217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnostic significance of carcinoembryonic antigen measurement in bronchial lavage fluids in bronchial carcinoma].
    Ma WL
    Zhonghua Jie He He Hu Xi Za Zhi; 1990 Dec; 13(6):349-50, 380-1. PubMed ID: 1964877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunocytochemical panel for the identification of malignant cells in serous effusions.
    Nance KV; Silverman JF
    Am J Clin Pathol; 1991 Jun; 95(6):867-74. PubMed ID: 1710419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expanding the morphologic spectrum of differentiated VIN (dVIN) through detailed mapping of cases with p53 loss.
    Singh N; Leen SL; Han G; Faruqi A; Kokka F; Rosenthal A; Jiang XR; Kim R; McAlpine JN; Gilks CB
    Am J Surg Pathol; 2015 Jan; 39(1):52-60. PubMed ID: 25025443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p53 immunolocalization in cell block preparations of squamous lesions of the neck: an adjunct to fine-needle aspiration diagnosis of malignancy.
    Khurana KK; Ramzy I; Truong LD
    Arch Pathol Lab Med; 1999 May; 123(5):421-5. PubMed ID: 10235501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic value of CA 15-3 antibody in detecting metastatic adenocarcinoma.
    Huang Y; Zimmerman RL; Bibbo M
    Anal Quant Cytol Histol; 2004 Oct; 26(5):259-62. PubMed ID: 15560531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic cytological evaluation and immunocytochemistry of minichromosome maintenance protein 2 and p53 significantly improve cytological diagnosis of pancreaticobiliary adenocarcinoma.
    Abe N; Matsuo K; Kumasaka T; Naka K; Hashimoto S; Takemura T; Fujiwara M; Ito Y; Nakata R; Hashimoto T; Makuuchi M; Soejima Y; Sawabe M
    J Med Dent Sci; 2016; 63(1):19-27. PubMed ID: 27181487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The utility of fine-needle aspiration in the diagnosis of primary and metastatic tumors to the lung: a retrospective examination of 1,032 cases.
    Adams J; Wu HH
    Acta Cytol; 2012; 56(6):590-5. PubMed ID: 23207436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of p63 as an effective immunomarker in the diagnosis of pulmonary squamous cell carcinomas on de-stained bronchial lavage cytological smears.
    Uke M; Rekhi B; Ajit D; Jambhekar NA
    Cytopathology; 2010 Feb; 21(1):56-63. PubMed ID: 19744186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differentiating reactive mesothelial cells from metastatic adenocarcinoma in serous effusions: the utility of immunocytochemical panel in the differential diagnosis.
    Saleh HA; El-Fakharany M; Makki H; Kadhim A; Masood S
    Diagn Cytopathol; 2009 May; 37(5):324-32. PubMed ID: 19191294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Morphologic changes of fallopian tubal epithelium in ovarian serous tumors].
    Wen J; Shi JL; Shen DH; Chen YX; Song QJ
    Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):433-7. PubMed ID: 22932451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive survival markers in patients with surgically resected non-small cell lung carcinoma.
    Moldvay J; Scheid P; Wild P; Nabil K; Siat J; Borrelly J; Marie B; Farré G; Labib T; Pottier G; Sesboüé R; Bronner C; Vignaud JM; Martinet Y; Martinet N
    Clin Cancer Res; 2000 Mar; 6(3):1125-34. PubMed ID: 10741743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation].
    Szczepulska-Wójcik E; Langfort R; Roszkowski-Sliz K
    Pneumonol Alergol Pol; 2007; 75(1):57-69. PubMed ID: 17541913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution of basal/myoepithelial markers in benign and malignant bronchioloalveolar proliferations of the lung.
    Saad RS; Liu YL; Silverman JF
    Appl Immunohistochem Mol Morphol; 2010 May; 18(3):219-25. PubMed ID: 20065853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of fibronectin in immuocytochemial differentiation of reactive mesothelial cells from metastatic malignant cells in serous effusions.
    Agarwal C; Jain M
    Indian J Pathol Microbiol; 2009; 52(1):25-8. PubMed ID: 19136774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility of WT-1, p63, MOC31, mesothelin, and cytokeratin (K903 and CK5/6) immunostains in differentiating adenocarcinoma, squamous cell carcinoma, and malignant mesothelioma in effusions.
    Pu RT; Pang Y; Michael CW
    Diagn Cytopathol; 2008 Jan; 36(1):20-5. PubMed ID: 18064689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions.
    Miédougé M; Rouzaud P; Salama G; Pujazon MC; Vincent C; Mauduyt MA; Reyre J; Carles P; Serre G
    Br J Cancer; 1999 Nov; 81(6):1059-65. PubMed ID: 10576665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.